Irfhan Ali Hyder Ali

14 OCT 2022
Friday

Time Session
11:50
12:40
Company: Boehringer Ingelheim (Malaysia) Sdn Bhd
Irfhan Ali Hyder Ali Chairperson
  • 2022 ATS/ERS/ALAT/JRS Clinical Practice Guidelines: An update on Diagnosis and Treatment of Progressive Pulmonary Fibrosis
Ballroom 2, Lower Ground Floor

15 OCT 2022
Saturday

Time Session
12:10
13:00
Company: Boehringer Ingelheim (Malaysia) Sdn Bhd
Irfhan Ali Hyder Ali Chairperson
  • The G.O.L.D Standard: Maximizing bronchodilator therapy for COPD patients
Ballroom 1, Lower Ground Floor
14:00
15:00
15:00
15:50
Company: Sanofi
Irfhan Ali Hyder Ali Chairperson
  • Expanding horizons: Targeting type 2 inflammation as a promising therapeutic strategy
  • Expanding horizons: Influenza is back: Evidence and impact
    Cheah Wee Kooi Speaker
Ballroom 2, Lower Ground Floor